Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease

被引：0
|
作者：
Saleem, R. [1 ]
Dubois, P. [1 ]
Chung-Faye, G. [1 ]
Bjarnason, I. [1 ]
Hayee, B. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60602-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P482
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [1] Early change in faecal calprotectin predicts primary non-response to anti-TNF therapy in Crohn's disease
    Pavlidis, Polychronis
    Gulati, Shraddha
    Dubois, Patrick
    Chung-Faye, Guy
    Sherwood, Roy
    Bjarnason, Ingvar
    Hayee, Bu'Hussain
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (12) : 1447 - 1452
  • [2] Faecal calprotectin as therapeutic target in patients with Crohn's disease treated with anti-TNF: a meta-analysis of individual data
    Mami, A.
    Nancey, S.
    Pugliese, D.
    Molander, P.
    Boschetti, G.
    Nogueira, I.
    Pereira, B.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S205 - S206
  • [3] FAECAL CALPROTECTIN AS THERAPEUTIC TARGET IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF: A META-ANALYSIS OF INDIVIDUAL DATA
    Mami, Alia
    Nancey, Stephane
    Pugliese, Daniela
    Molander, Pauliina
    Boschetti, Gilles
    Nogueira, Islaine
    Pereira, Bruno
    Buisson, Anthony
    GASTROENTEROLOGY, 2020, 158 (06) : S708 - S708
  • [4] TRANSMURAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF THERAPY
    Pastaud, Clement
    Hordonneau, Constance
    Lambert, Celine
    Vignette, Jeanne
    Pereira, Bruno
    Buisson, Anthony
    GASTROENTEROLOGY, 2020, 158 (06) : S953 - S954
  • [5] The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease
    Sollelis, E.
    Quinard, R. Minet
    Bouguen, G.
    Goutte, M.
    Goutorbe, F.
    Bouvier, D.
    Pereira, B.
    Bommelaer, G.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S360 - S360
  • [6] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [7] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [8] FAECAL CALPROTECTIN IDENTIFIES NON RESPONDERS TO ANTI-TNF THERAPY WHEN MEASURED AFTER INDUCTION IN INFLAMMATORY CROHN'S DISEASE
    Pavlidis, P.
    Cavazza, A.
    Siddique, N.
    Stamoulos, P.
    Tumova, J.
    Medcalf, L.
    Chung-Faye, G.
    Dubois, P.
    Bjarnason, I.
    Hayee, B.
    GUT, 2015, 64 : A431 - A432
  • [9] Another anti-TNF therapy for patients with Crohn's disease
    Cross, Raymond
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 425 - 427
  • [10] Anti-TNF therapy for Crohn's disease
    D'Haens, G
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 289 - 294
12345